https://investor.ironwoodpharma.com/press-releases/press-release-details/2016/Ironwood-Pharmaceuticals-Reports-Top-Line-Data-from-Exploratory-Phase-IIa-Study-of-IW-9179-in-Diabetic-Gastroparesis/default.aspx
Ironwood Pharmaceuticals is a leading gastrointestinal (GI) healthcare company on a mission to advance the treatment of GI diseases and redefine the standard of care for GI patients.
- April 5, 2016